Abstract:Background There is increasing evidence that oxidative stress, overproduction of reactive oxygen species (ROS) originating from nicotinamide adenine dinucleotide phosphate [NAD(P)H]oxidase, plays a critical role in the development and progression of cardiac remodeling associated with heart failure. Many experimental and clinical studies have reported that tanshinone Ⅱ A(Tan Ⅱ A) is an anti-oxidant effective for inibition of atherosclerosis. However, no studies have addressed the effect of TanⅡ A on cardiac hypertrophy. Objective To study the effects of Tan Ⅱ A on left ventricular hypertrophy induced by renovascular hypertension after two-kidney two-clip (2K2C) operation, and the impossible underlying mechanism. Methods There were 5 groups in the experiment: control: rats received sham operation and given 0.5% carboxymethylcellulose sodium; 2K2C: rats received 2K2C operation and given 0.5% carboxymethylcellulose sodium;valsartan:2K2C rats given valsartan[30mg/(kg·d)];TanH:2K2C rats given Tan Ⅱ A [70mg/(kg·d)]and TanL:2K2C rats given Tan Ⅱ A [35mg/(kg·d)].At the endpoint of the experiment, echoeardiography was performed. Then the rats were sacrificed, body mass (BM) and left ventricule mass (LVM) were determined, and the LVMI was calculated.The oxidative fluorescence dye dihydroethidium detected by laser confocal fluorescent microscopy was used to evaluae in situ O_2·~- generation in the LV and aorta. The NAD(P)H oxidase activity in LV and aorta was estimated with lucigenin-enhanced chemilumi-nescence. Results Compared with the control rats, BP of 2K2C rats was elevated to about 180 mm Hg at week 4 after operation(P<0.05). Ten weeks after operation, 2K2C rats developed obvious LV hypertrophy, with enhanced O_2·~- generation and NAD(P)H oxidase activity in LV and aorta (P<0.05).Tan ⅡA ,more significantly in high dose,attenuated LVH (P<0.05) and reverade the over oxidative stress by inhibiting generation of O_2·~-(P<0.05)and the activation of NAD(P) H oxidase(P<0.05) in LV and aorta after treatment for 6 weeks though BP was not decreased significantly, while valsartan, not only attenuated LVH and oxidative stress, but also decreased BP markedly. Conclusion Tan Ⅱ A significantly reverse the LV hypertrophy in 2K2C rats, that might be associated with attenuation of NAD(P)H oxidase-derived reactive oxygen species production.

Tanshinone IIA Prevents Rat Basilar Artery Smooth Muscle Cells Proliferation by Inactivation of PDK1 During the Development of Hypertension

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB.

Protective Effects of Tanshinone IIA on Endothelial Progenitor Cells Injured by Tumor Necrosis Factor-Α

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Tanshinone IIA Prevents Cardiac Remodeling Through Attenuating NAD (P)H Oxidase-Derived Reactive Oxygen Species Production in Hypertensive Rats.

[Effect of Tanshinone II A on the Transforming Growth Factor Beta1/smads Signal Pathway in Rats with Hypertensive Myocardial Hypertrophy].

Tanshinone ⅡA Inhibits Homocysteine-Induced Proliferation of Vascular Smooth Muscle Cells Via Mir-145/Cd40 Signaling.

Tanshinone IIA protects PC12 cells from β-amyloid-induced apoptosis via PI3K/Akt signaling pathway

Tanshinone Ⅱ A Attenuated Oxidative Stress and Left Ventricular Hypertrophy Induced by Renovascular Hypertension

Tanshinone IIA protects PC12 cells from β-amyloid 25–35 -induced apoptosis via PI3K/Akt signaling pathway

Tanshinone IIA protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway

Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A

Tanshinone IIA Attenuates Renal Damage in STZ-induced Diabetic Rats Via Inhibiting Oxidative Stress and Inflammation.

Tanshinone IIA Protects Hippocampal Neuronal Cells from Reactive Oxygen Species Through Changes in Autophagy and Activation of Phosphatidylinositol 3-Kinase, Protein Kinas B, and Mechanistic Target of Rapamycin Pathways

Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension

Tanshinone Iia Protects Against Cardiac Hypertrophy Via Inhibiting Calcineurin/Nfatc3 Pathway

Tanshinone IIA Suppresses Hypoxia-induced Apoptosis in Medial Vestibular Nucleus Cells Via a Skp2/BKCa Axis

Simvastatin Attenuated Cerebrovascular Cell Proliferation in the Development of Hypertension Through Rho/Rho-Kinase Pathway

Tanshinone IIA Protected Against Lipopolysaccharide-Induced Brain Injury Through the Protective Effect of the Blood-Brain Barrier and the Suppression of Oxidant Stress and Inflammatory Response.

Tanshinone IIA Protects Cardiac Myocytes Against Oxidative Stress-Triggered Damage and Apoptosis.

The intervention mechanism of Tanshinone IIA in alleviating neuronal injury induced by HMGB1 or TNF-α-mediated microglial activation